Online citations, reference lists, and bibliographies.
← Back to Search

Safety And Pharmacokinetics Of MM-302, A HER2-targeted Antibody–liposomal Doxorubicin Conjugate, In Patients With Advanced HER2-positive Breast Cancer: A Phase 1 Dose-escalation Study

Pamela Munster, Ian E. Krop, Patricia LoRusso, Cynthia Ma, Barry A. Siegel, Anthony F. Shields, István Molnár, Thomas J. Wickham, Joseph Reynolds, Karen Campbell, Bart S. Hendriks, Bambang S. Adiwijaya, Elena Geretti, Victor Moyo, Kathy D. Miller

Save to my Library
Download PDF
Analyze on Scholarcy
Share